|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Short-term deposits | ||||||||||||||||||||
| Accounts receivable (net of allowances of $1,458 and $1,260 at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Prepaid expenses and other short-term assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Long-term assets: | ||||||||||||||||||||
| Long-term marketable securities | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders’ equity | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Trade payables | ||||||||||||||||||||
| Accrued expenses and other short-term liabilities | ||||||||||||||||||||
| Convertible senior notes, net | ||||||||||||||||||||
| Deferred revenues | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Convertible senior notes, net | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Deferred revenues | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock of $0.001 par value - Authorized: 200,000,000 shares at June 30, 2026 and December 31, 2025; Issued and outstanding: 114,853,875 shares at June 30, 2026 and 117,546,852 shares at December 31, 2025 | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity |
Loading...
